PHARMACOGENOMIC DETERMINANTS OF TREATMENT RESPONSE IN OSTEOARTHRITIS: THE ROLE OF ABCB1 (MDR1) GENE POLYMORPHISMS IN PERSONALIZING DISEASE-MODIFYING THERAPY

Authors

  • Dilnavo Ziyotdinova Автор
  • Temurbek Mamatmuminov Автор

DOI:

https://doi.org/10.5281/zenodo.18796722

Abstract

Osteoarthritis is the most prevalent chronic joint disorder worldwide and a leading cause of pain, functional limitation, and disability among adults and elderly populations. Traditionally considered a degenerative disease driven primarily by mechanical wear and tear, osteoarthritis is now recognized as a complex, multifactorial condition involving low-grade inflammation, metabolic dysregulation, genetic susceptibility, and alterations in subchondral bone remodeling. The global burden of osteoarthritis continues to rise due to aging populations, increasing obesity rates, and sedentary lifestyles. Despite advances in symptomatic management, many patients experience persistent pain, progressive structural damage, and substantial deterioration in quality of life. 

 

Downloads

Published

2026-02-27

Issue

Vol. 2 No. 2 (2026): International Conference on Science & Technology (ICST)

Section

Статьи

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

By submitting a paper to the conference organized by Academic Publishing House, the author(s) agree to the following license terms and conditions:

1. Copyright and Licensing

  1. The author(s) retain the copyright of their article.

  2. The author(s) grant Academic Publishing House a non-exclusive license to publish, distribute, and archive the submitted material in both electronic and print formats.

  3. The work will be published under the Creative Commons Attribution (CC BY 4.0) license, allowing others to share and adapt the material for any purpose, provided proper credit is given to the original author(s).

2. Author’s Responsibilities

  1. The author(s) guarantee that the submitted work is original, does not infringe any existing copyrights, and has not been published or submitted elsewhere.

  2. The author(s) confirm that all co-authors have approved the final version of the manuscript and agree with its submission and publication.

  3. The author(s) are fully responsible for the accuracy of the data, citations, and references provided in the article.

3. Publisher’s Rights

  1. Academic Publishing House reserves the right to edit, format, and make minor grammatical or layout corrections to the paper without altering its core content.

  2. The publisher has the right to include the article in indexing databases, archives, and repositories such as Google Scholar, Zenodo, OpenAIRE, and other partner platforms.

  3. The publisher may promote the paper through its website and official social media channels.

4. Open Access Policy

All conference papers are published as open access, ensuring free and permanent online access to the full text of all articles immediately upon publication.

5. Withdrawal and Retraction

If ethical misconduct, plagiarism, or data manipulation is detected, Academic Publishing House reserves the right to withdraw or retract the publication at any stage.

6. Acceptance of Terms

Submission of a manuscript to the conference implies that the author(s) have read, understood, and accepted these License Terms.

How to Cite

Ziyotdinova, D., & Mamatmuminov, T. (2026). PHARMACOGENOMIC DETERMINANTS OF TREATMENT RESPONSE IN OSTEOARTHRITIS: THE ROLE OF ABCB1 (MDR1) GENE POLYMORPHISMS IN PERSONALIZING DISEASE-MODIFYING THERAPY. International Conference on Science & Technology, 2(2), 137-143. https://doi.org/10.5281/zenodo.18796722